CE vs INTS
Celanese Corporation (CE) versus Intensity Therapeutics, Inc. Common stock (INTS) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
INTS does not have a complete income-statement cache yet.
CE currently screens at market cap $5.92B. INTS currently screens at market cap $7.7M.
Not investment advice. Open the CE and INTS stock pages for the full models.
Not investment advice.